Clinical trial/clinical trial/Sernova

Cell Pouch islet transplant

A durable, retrievable implant site is a key piece of the cell-therapy puzzle, and is being combined with newer approaches to reduce or remove immunosuppression.

How it works

An implanted 'Cell Pouch' is allowed to grow its own blood supply, then donor islet cells are placed inside it to produce insulin in a protected, vascularized site.

Approach
Implantable bio-hybrid organ
Immunosuppression
Currently used with immunosuppression

Live trial status

NCT03513939ACTIVE NOT RECRUITING

A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouchâ„¢ for Clinical Islet Transplantation

Phase: PHASE1, PHASE2Enrollment: 17Updated: Feb 24, 2026
Open ClinicalTrials.gov record

These are research programs pursuing a functional cure or disease modification for type 1 diabetes. None is a confirmed, broadly available cure. Trial status is informational, not medical advice, and not a recruiting offer. Verify eligibility and details with the official trial record and a clinician.

Family-tested T1D gear

Some links below are affiliate links. If you buy through them, Type1Cure may earn a small commission at no extra cost to you. Affiliate relationships never affect our research coverage, evidence labels, rankings, or safety alerts.